Tower Research Capital LLC (TRC) - ATHIRA PHARMA INC ownership

ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 110 filers reported holding ATHIRA PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ATHIRA PHARMA INC
ValueSharesWeighting
Q3 2023$327
+1386.4%
162
-98.2%
0.00%
-100.0%
Q1 2023$22
-68.6%
8,821
-59.8%
0.00%
-66.7%
Q4 2022$70
-99.9%
21,966
+22.1%
0.00%
+200.0%
Q3 2022$53,000
+783.3%
17,991
+853.9%
0.00%
Q2 2022$6,000
-68.4%
1,886
+37.1%
0.00%
Q1 2022$19,000
+90.0%
1,376
+83.7%
0.00%
Q4 2021$10,000
-69.7%
749
-78.4%
0.00%
-100.0%
Q3 2021$33,000
+17.9%
3,462
+28.0%
0.00%0.0%
Q2 2021$28,000
+40.0%
2,704
+144.3%
0.00%
Q1 2021$20,000
+42.9%
1,107
+172.0%
0.00%
Q4 2020$14,0004070.00%
Other shareholders
ATHIRA PHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
BML Capital Management, LLC 714,763$2,265,7992.16%
Perceptive Advisors 4,797,278$15,207,3710.43%
Potomac Capital Management, Inc. 80,000$2540.30%
Bristlecone Advisors, LLC 696,629$2,208,3140.27%
TANG CAPITAL MANAGEMENT LLC 485,234$1,538,1920.22%
RA Capital Management 1,881,300$5,963,7210.12%
GSA CAPITAL PARTNERS LLP 270,989$8590.11%
PATHSTONE FAMILY OFFICE, LLC 3,631,080$8,182,6500.07%
Laird Norton Wetherby Trust Company, LLC 130,000$412,1000.06%
Forefront Analytics, LLC 22,350$70,8510.04%
View complete list of ATHIRA PHARMA INC shareholders